Department of Diabetes Metabolism and E... Publications

Clinical Trial Review Systematic Review Meta-Analysis Books and Documents Randomized Controlled Trial

1 results match your criteria: "Department of Diabetes Metabolism and Endocrinology Sakai City Medical Center Sakai Japan.[Affiliation]"

Page 1 of 1

Acute worsening of glycemic control in a patient with type 2 diabetes and non-small cell lung cancer after administration of lorlatinib.

Clin Case Rep

January 2022

Department of Diabetes Metabolism and Endocrinology Sakai City Medical Center Sakai Japan.

Yoshio Nakano Mai Miyasato-Isoda Iwao Gohma Tomomi Fujisawa

A patient with non-small cell lung cancer (NSCLC) exhibited extreme hyperglycemia after lorlatinib treatment. The present case highlights the importance of glucose monitoring during lorlatinib administration and intensifying hyperglycemia treatment.

View Article and Find Full Text PDF

Similar Publications

Geographic Location

Publish Date

Article Type

Acute worsening of glycemic control in a patient with type 2 diabetes and non-small cell lung cancer after administration of lorlatinib.